logo
Plus   Neg
Share
Email

Tiffany Shareholders Approve Its Acquisition By LVMH

Tiffany & Co. (TIF) Tuesday said its shareholders approved its acquisition by French luxury products maker LVMH Moët Hennessy Louis Vuitton SE or LVMH Group (LVMHF.PK,LVMUY.PK).

The stockholders approved certain compensation arrangements for named executive officers in connection with the merger.

The company announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with the merger for U.S. antitrust purposes expired as of February 3, 2020.

In November, LVMH agreed to buy the jeweler for $135 per share in cash. The transaction has an equity value of approximately 14.7 billion euros or $16.2 billion.

LVMH expects the acquisition of Tiffany would strengthen its position in jewelry and further increase its presence in the United States. The addition of Tiffany will transform LVMH's Watches & Jewelry division and complement LVMH's 75 distinguished Houses.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration on Saturday authorized Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine for emergency use. It is the first single-shot COVID-19 vaccine and the third COVID-19 vaccine for emergency use in the U.S. - the other two being Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273. The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate. Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year.
Follow RTT